BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10520225)

  • 1. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
    Yamada M; Kawai M; Kawai Y; Mashima Y
    Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK; Hirasawa N; Niki H; Ohuchi K
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
    Boyan BD; Lohmann CH; Sisk M; Liu Y; Sylvia VL; Cochran DL; Dean DD; Schwartz Z
    J Biomed Mater Res; 2001 Jun; 55(3):350-9. PubMed ID: 11255188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
    Castro MR; Lutz D; Edelman JL
    Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites.
    Ottino P; Bazan HE
    Curr Eye Res; 2001 Aug; 23(2):77-85. PubMed ID: 11840344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.
    Yamamoto T; Nozaki-Taguchi N
    Brain Res; 1996 Nov; 739(1-2):104-10. PubMed ID: 8955930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2.
    Blikslager AT; Zimmel DN; Young KM; Campbell NB; Little D; Argenzio RA
    Gut; 2002 May; 50(5):615-23. PubMed ID: 11950805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE; Moore SA; Faraci FM
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons.
    Luo J; Lindström CL; Donahue A; Miller MW
    J Neurochem; 2001 Mar; 76(5):1354-63. PubMed ID: 11238720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism.
    Nédélec E; Abid A; Cipolletta C; Presle N; Terlain B; Netter P; Jouzeau J
    Biochem Pharmacol; 2001 Apr; 61(8):965-78. PubMed ID: 11286988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
    Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
    Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.